Retraction
Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation
Paper Information
Record ID:
57295
Author(s):
Journal:
Publication Date:
March 09, 2022
Retraction Date:
January 09, 2024
(1.9 year years ago)
Subjects:
Institutions:
- Department of Biological Science, Gachon University, Seongnam 13120, Republic of Korea
- Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea
- Department of Bio and Chemical Engineering, Hongik University, Sejong 30016, Republic of Korea
- Department of Biological Engineering, Konkuk University, Seoul 05029, Republic of Korea
- Department of Pathology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea
- Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju 54896, Republic of Korea
- Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54896, Republic of Korea
Country:
🇰🇷 South KoreaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations2
Post-Retraction(22.2%)
5
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
144
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
In vivo transgenic studies confirm the critical acylation function of LeBAHD56 for shikonin in Lithospermum erythrorhizon
Yang Liu, Changyi Wang, Xiaohui Lai et al. (16 authors)
Plant Cell Reports
Published: Jun 2024
144 days after retraction
CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control
Jacqueline Wen Hui Leow, Eric Chun Yong Chan
Pharmacology & Therapeutics
Published: Mar 2024
2 citations
2 citations
73 days after retraction
Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2024
2 citations
2 citations
Same day as retraction
Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer
S.M. Lin, Tsung‐Ming Chang, Augusta I‐Chin Wei et al. (8 authors)
Aging
Open Access
Published: Dec 2023
6 citations
6 citations
21 days before retraction
Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF<sub>2α</sub>/CHOP axis in oesophageal squamous cell carcinoma
Ya‐Jiao Yuan, Shanshan Liu, Hong Yang et al. (7 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Nov 2023
6 citations
6 citations
64 days before retraction
Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial-Dependent Apoptosis in GBM Cells, Which Is Regulated by Autophagy
Sima Hajiahmadi, Shahrokh Lorzadeh, Rosa Iranpour et al. (7 authors)
Biology
Open Access
Published: Feb 2023
25 citations
25 citations
329 days before retraction
Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial Dependent Apoptosis in GBM Cells which is Regulated by Autophagy
Sima Hajiahmadi, Shahrokh Lorzadeh, Rosa Iranpour et al. (7 authors)
Unknown Journal
Open Access
Published: Jan 2023
6 citations
6 citations
361 days before retraction
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2
Ayaka Kojima, Masayuki Nadai, Norie Murayama et al. (5 authors)
Xenobiotica
Open Access
Published: Jul 2022
2 citations
2 citations
555 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025